Search
forResearch 10 of 1000+
- First-in-human phase 1 study of ETC-159 an oral PORCN inhbitor in patients with advanced solid tumours.
- Bone Metabolism in Patients with Hidradenitis Suppurativa: A Case-control Study
- Microneedles meet photomedicine: emerging strategies for diagnosis and therapy of skin diseases
- Krtap16, Characterization of a New Hair Keratin-associated Protein (KAP) Gene Complex on Mouse Chromosome 16 and Evidence for Regulation by Hoxc13
- Titagen® for total wellness: results from a randomised, placebo controlled clinical study on adults for osteoarthritis, improvement in skin, nail and health
- Chemotherapy-Induced Alopecia
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Collagen supplementation and regenerative health: advances in biomarker detection and smart material integration
- The Rotterdam Study: 2016 objectives and design update
- Interferon alfa-2a in the treatment of cutaneous T cell lymphoma
Community 3 of 4
- Oral v topical Min & Dutasteride
- Day 1 v 3 month progress. Topical Spray used in the UK.
- Is 0.1%w/v topical fin overkill if taking oral 0.5mg fin?
Learn
— no results
Try a deeper search in learn →